Articles By Marcus Johnson
- 
                    Experimental Brain Cancer Drug Shows Potential
                        3/25/2014
                    
An experimental brain cancer drug has shown potential for treating patients with an aggressive form of the disease.
 - 
                    K-PAX Pharmaceuticals Develops Chronic Fatigue Syndrome Treatment
                        3/25/2014
                    
A pharmaceutical company based out of Mill Valley has developed a treatment for chronic fatigue sydrome.
 - 
                    Cancer Institutes Are Increasingly Asking Big Pharma For Funding
                        3/10/2014
                    
Budget cuts and other state imposed austerity measures have led to a lack of funding for many cancer research institutes. These institutes are increasingly turning to the pharmaceutical industry to get the funding that they need in order to continue their research.
 - 
                    i4Health Attempted To Access All Of UK's Patient Records
                        3/7/2014
                    
An information firm associated with several pharmaceutical companies attempted to sign an agreement that would have given them direct access to the UK’s new medical database.
 - 
                    Nanoparticle Drug Delivery System Used To Target Cancer
                        3/6/2014
                    
Researchers are working on a new cancer treatment that will allow doctors to directly target tumors in chemotherapy. The new treatment consists of a nanoparticle drug delivery system that uses laser light.
 - 
                    Health Advocates Lobbying FDA To Stop Sale Of Painkiller
                        3/5/2014
                    
The FDA has already approved the release of Zogenix manufactured painkiller Zohydro. However, health advocates and doctors have begun a campaign to lobby the FDA to reconsider their course of action.
 - 
                    New Drugs Improve Learning In Children With Down Syndrome
                        3/5/2014
                    
Drug makers such as Roche and Balance Therapeutics are working on new drugs that will improve the learning abilities of children with Down syndrome.
 - 
                    Pharmaceutical Companies Slash Spending On Promotional Speakers
                        3/5/2014
                    
There is a growing trend of pharmaceutical companies operating in the US cutting promotional speaking payments.
 - 
                    Avastin Study Shows The Drug Doesn't Help Brain Cancer Patients
                        3/4/2014
                    
Researchers had hoped the drug Avastin could be used to treat patients with brain cancer. A study published in The New England Journal Medicine has shown that the drug actually worsened a patient’s quality of life and decreased cognitive function.
 - 
                    Drug-Eluting Balloon Angioplasty Treatment Has Potential
                        2/26/2014
                    
Drug-eluting balloons have shown promise as a treatment for restenosis in diabetic populations. In 40 percent of patients that get treatment for blocked arteries, those arteries will become obstructed once again.